Description
Ipamorelin is a synthetic pentapeptide (Aib-His-D-2-Nal-D-Phe-Lys-NH2) that acts as a selective agonist of the ghrelin/growth hormone secretagogue receptor. As a growth hormone secretagogue, it stimulates the release of growth hormone (GH) from the pituitary gland. Its mechanism of action mimics that of ghrelin, binding to the GHSR-1a receptor to induce a strong and sustained release of GH. Unlike other growth hormone releasing peptides, Ipamorelin does not significantly affect the levels of other hormones such as cortisol, prolactin, or acetylcholine, making it a highly selective agent.
Key research areas for Ipamorelin include its potential to increase bone mineral density, stimulate gastric motility, and improve lean body mass. Studies have explored its effects on postoperative ileus, as well as its role in various age-related conditions. Its selective nature and favorable side effect profile have made it a subject of interest in numerous preclinical and clinical investigations.
This product is intended for research purposes only and is not for human or veterinary use. It should be handled by qualified professionals in a laboratory setting.
CAS: 170851-70-4
PubChem CID: 9831659
Molecular Formula: C38H49N9O5
Molecular Weight: 711.85 g/mol
Amino Acid Sequence: Aib-His-D-2-Nal-D-Phe-Lys-NH₂ (5 aa, modified)
Physical Form: Lyophilized Powder
Purity: ≥99%
Storage: -20°C, protected from light and moisture


